Prelude Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-137,500
Closed -$7.23M 1909
2022
Q2
$7.23M Buy
+137,500
New +$9.57M 0.21% 66
2020
Q3
Sell
-115,000
Closed -$2.08M 2338
2020
Q2
$2.08M Buy
+115,000
New +$2.27M 0.11% 158

Other funds holding THC

Prelude Capital Management's THC Position: Q1 2026 in Review

Prelude Capital Management reduced its Tenet Healthcare (THC) stake by 54% in Q1 2026, selling an estimated $424K and leaving 1,743 shares worth $329K. The position accounts for 0.03% of the portfolio, ranked #673.

Prelude Capital Management first reported a position in THC in Q4 2013 and has held it in 39 quarters since. The position peaked at $7.54M in Q1 2024. 692 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Prelude Capital Management held 1,743 shares of Tenet Healthcare worth $329K as of Q1 2026.
  • Prelude Capital Management sold 2,011 Tenet Healthcare shares in Q1 2026, an estimated $424K.
  • Tenet Healthcare made up 0.03% of Prelude Capital Management's portfolio in Q1 2026, its #673 holding.
  • Prelude Capital Management first reported a position in Tenet Healthcare in Q4 2013 and has held it in 39 quarters since.
  • Prelude Capital Management's Tenet Healthcare position peaked at $7.54M in Q1 2024.
  • 692 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.